I
Isabelle C. Van Gelder
Researcher at University Medical Center Groningen
Publications - 351
Citations - 56632
Isabelle C. Van Gelder is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Atrial fibrillation & Heart failure. The author has an hindex of 74, co-authored 326 publications receiving 44197 citations. Previous affiliations of Isabelle C. Van Gelder include University of Groningen & University of Southern Denmark.
Papers
More filters
Journal ArticleDOI
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration
Ben Freedman,John Camm,Hugh Calkins,Jeff S. Healey,Mårten Rosenqvist,Jiguang Wang,Christine M. Albert,Craig S. Anderson,Sotiris Antoniou,Emelia J. Benjamin,Giuseppe Boriani,Johannes Brachmann,Axel Brandes,Tze-Fan Chao,David Conen,Johan Engdahl,Laurent Fauchier,David A Fitzmaurice,Leif Friberg,Bernard J. Gersh,David J. Gladstone,Taya V. Glotzer,Kylie Gwynne,Graeme J. Hankey,Joseph Harbison,Graham S. Hillis,Mellanie True Hills,Hooman Kamel,Paulus Kirchhof,Peter R. Kowey,Derk Krieger,Vivian W Y Lee,Lars-Åke Levin,Gregory Y.H. Lip,Trudie Lobban,Nicole Lowres,Georges H. Mairesse,Carlos Martinez,Lis Neubeck,Jessica Orchard,Jonathan P. Piccini,Katrina Poppe,Tatjana S. Potpara,Helmut Puererfellner,Michiel Rienstra,Roopinder K. Sandhu,Renate B. Schnabel,Chung-Wah Siu,Steven R. Steinhubl,Jesper Hastrup Svendsen,Emma Svennberg,Sakis Themistoclakis,Robert G. Tieleman,Mintu P. Turakhia,Arnljot Tveit,Steven B Uittenbogaart,Isabelle C. Van Gelder,Atul Verma,Rolf Wachter,Bryan P. Yan +59 more
TL;DR: A strong case for AF screening now is provided while recognizing that large randomized outcomes studies would be helpful to strengthen the evidence base.
Journal ArticleDOI
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT
Isabelle C. Van Gelder,Jeff S. Healey,Harry J.G.M. Crijns,Jia Wang,Stefan H. Hohnloser,Michael R. Gold,Alessandro Capucci,Chu-Pak Lau,Carlos A. Morillo,Anne H Hobbelt,Michiel Rienstra,Stuart J. Connolly +11 more
TL;DR: SCAF duration >24 h was associated with a significant increased risk of subsequent stroke or systemic embolism, and patients with SCAF between 6 min and 24’h was not significantly different from patients without SCAF.
Journal ArticleDOI
Verapamil Reduces Tachycardia-Induced Electrical Remodeling of the Atria
Robert G. Tieleman,Cees D.J. De Langen,Isabelle C. Van Gelder,Pieter J de Kam,Jan G. Grandjean,KJ Bel,Maurits C.E.F. Wijffels,Maurits A. Allessie,Harry J.G.M. Crijns +8 more
TL;DR: Electrical remodeling of the atrium during rapid atrial pacing was significantly attenuated by verapamil, which suggests that electrical remodelling of theAtrial effective refractory period is triggered by the high calcium influx during rapidatrial pacing rates.
Journal ArticleDOI
Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries The RE-LY Atrial Fibrillation Registry
Jonas Oldgren,Jeff S. Healey,Michael D. Ezekowitz,Patrick J. Commerford,Alvaro Avezum,Prem Pais,Jun Zhu,Petr Jansky,Alben Sigamani,Carlos A. Morillo,Lisheng Liu,Albertino Damasceno,Alex Grinvalds,Juliet Nakamya,Paul A. Reilly,Katalin Keltai,Isabelle C. Van Gelder,Afzalhussein Yusufali,Eiichi Watanabe,Lars Wallentin,Stuart J. Connolly,Salim Yusuf +21 more
TL;DR: In this article, the most common sustained arrhythmia is atrial fibrillation (AF) and little is known about patients in a primary care setting from high-, middle-, and low-income countries.
Journal ArticleDOI
Plakophilin-2 Mutations Are the Major Determinant of Familial Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
J. Peter van Tintelen,Mark M. Entius,Zahurul A. Bhuiyan,Roselie Jongbloed,Ans C.P. Wiesfeld,Arthur A.M. Wilde,Jasper J. van der Smagt,Ludolf G. Boven,Marcel M.A.M. Mannens,Irene M. van Langen,Robert M. W. Hofstra,Luuk C. Otterspoor,Pieter A. Doevendans,Luz-Maria Rodriguez,Isabelle C. Van Gelder,Richard N.W. Hauer +15 more
TL;DR: In this paper, mutations in the plakophilin-2 gene (PKP2) were found in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC).